

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.75173697 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.68289818 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.68289818 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.04330619 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.84508221 |
| 6 | leukocyte aggregation (GO:0070486) | 4.75180866 |
| 7 | detection of other organism (GO:0098543) | 4.74112523 |
| 8 | detection of bacterium (GO:0016045) | 4.64447492 |
| 9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.56933274 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.52784417 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.32795106 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.29410572 |
| 13 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.29263402 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.21980962 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.21980962 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11924971 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.95825291 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 3.95424875 |
| 19 | negative regulation of T cell mediated immunity (GO:0002710) | 3.93444632 |
| 20 | detection of external biotic stimulus (GO:0098581) | 3.93099499 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 3.91339445 |
| 22 | respiratory burst (GO:0045730) | 3.87265159 |
| 23 | immunoglobulin mediated immune response (GO:0016064) | 3.84889702 |
| 24 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.84576381 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.82380400 |
| 26 | regulation of B cell differentiation (GO:0045577) | 3.82108910 |
| 27 | mast cell activation (GO:0045576) | 3.79463031 |
| 28 | T cell migration (GO:0072678) | 3.75466474 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.72458587 |
| 30 | activated T cell proliferation (GO:0050798) | 3.68999050 |
| 31 | negative T cell selection (GO:0043383) | 3.68426657 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 3.64357721 |
| 33 | microglial cell activation (GO:0001774) | 3.63151516 |
| 34 | regulation of mast cell degranulation (GO:0043304) | 3.62376551 |
| 35 | negative regulation of phagocytosis (GO:0050765) | 3.61952472 |
| 36 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.61646018 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.61617464 |
| 38 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.60787779 |
| 39 | B cell receptor signaling pathway (GO:0050853) | 3.58310422 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 3.51469661 |
| 41 | regulation of tolerance induction (GO:0002643) | 3.47461393 |
| 42 | detection of biotic stimulus (GO:0009595) | 3.47305639 |
| 43 | positive thymic T cell selection (GO:0045059) | 3.46565157 |
| 44 | interferon-gamma production (GO:0032609) | 3.45299906 |
| 45 | response to host immune response (GO:0052572) | 3.45139214 |
| 46 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.45139214 |
| 47 | response to interleukin-15 (GO:0070672) | 3.43956153 |
| 48 | ribosomal small subunit assembly (GO:0000028) | 3.43748590 |
| 49 | response to peptidoglycan (GO:0032494) | 3.38524781 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.38030592 |
| 51 | neutrophil mediated immunity (GO:0002446) | 3.36881865 |
| 52 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.33660949 |
| 53 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.33579188 |
| 54 | cellular extravasation (GO:0045123) | 3.31465222 |
| 55 | regulation of mast cell activation (GO:0033003) | 3.30038483 |
| 56 | macrophage activation (GO:0042116) | 3.29333774 |
| 57 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.28939794 |
| 58 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.28859666 |
| 59 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.28859666 |
| 60 | defense response to protozoan (GO:0042832) | 3.28678132 |
| 61 | response to protozoan (GO:0001562) | 3.26066038 |
| 62 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.23942849 |
| 63 | neutrophil activation (GO:0042119) | 3.21487465 |
| 64 | regulation of leukocyte degranulation (GO:0043300) | 3.18524463 |
| 65 | response to type I interferon (GO:0034340) | 3.17628071 |
| 66 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14739299 |
| 67 | type I interferon signaling pathway (GO:0060337) | 3.14669411 |
| 68 | cellular response to type I interferon (GO:0071357) | 3.14669411 |
| 69 | NIK/NF-kappaB signaling (GO:0038061) | 3.14169939 |
| 70 | negative regulation of innate immune response (GO:0045824) | 3.13937567 |
| 71 | B cell mediated immunity (GO:0019724) | 3.11910050 |
| 72 | response to host (GO:0075136) | 3.11762714 |
| 73 | response to host defenses (GO:0052200) | 3.11762714 |
| 74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.11762714 |
| 75 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11553317 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 3.11278942 |
| 77 | T cell homeostasis (GO:0043029) | 3.11062791 |
| 78 | regulation of regulatory T cell differentiation (GO:0045589) | 3.10967008 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.08626297 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.08626297 |
| 81 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08609022 |
| 82 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05949691 |
| 83 | positive regulation of mast cell degranulation (GO:0043306) | 3.05949691 |
| 84 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.05124642 |
| 85 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04675330 |
| 86 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.02943771 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 3.02943771 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 3.02943771 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 3.02943771 |
| 90 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.02943771 |
| 91 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.02943771 |
| 92 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.02145795 |
| 93 | response to muramyl dipeptide (GO:0032495) | 3.01716964 |
| 94 | leukocyte cell-cell adhesion (GO:0007159) | 3.01631258 |
| 95 | positive regulation of tolerance induction (GO:0002645) | 2.99886960 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 2.99348750 |
| 97 | thymic T cell selection (GO:0045061) | 2.99130166 |
| 98 | tolerance induction (GO:0002507) | 2.98974071 |
| 99 | granulocyte activation (GO:0036230) | 2.98895453 |
| 100 | actin nucleation (GO:0045010) | 2.98366911 |
| 101 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.98299991 |
| 102 | positive regulation of antigen processing and presentation (GO:0002579) | 2.98160372 |
| 103 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.98156606 |
| 104 | negative regulation of interleukin-12 production (GO:0032695) | 2.98124540 |
| 105 | positive regulation of interferon-alpha production (GO:0032727) | 2.97021660 |
| 106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96279692 |
| 107 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.93996044 |
| 108 | cellular response to interleukin-15 (GO:0071350) | 2.93757864 |
| 109 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.92343359 |
| 110 | leukocyte degranulation (GO:0043299) | 2.90222598 |
| 111 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88419375 |
| 112 | mast cell degranulation (GO:0043303) | 2.88165957 |
| 113 | mast cell activation involved in immune response (GO:0002279) | 2.88165957 |
| 114 | T cell selection (GO:0045058) | 2.88016998 |
| 115 | positive regulation of isotype switching (GO:0045830) | 2.85240596 |
| 116 | positive T cell selection (GO:0043368) | 2.84801296 |
| 117 | lymphocyte homeostasis (GO:0002260) | 2.84604322 |
| 118 | cellular response to zinc ion (GO:0071294) | 2.84121414 |
| 119 | regulation of interferon-alpha production (GO:0032647) | 2.83996426 |
| 120 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.82075099 |
| 121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.79276941 |
| 122 | response to fungus (GO:0009620) | 2.77277378 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.75134809 |
| 124 | viral transcription (GO:0019083) | 2.74961427 |
| 125 | response to interferon-beta (GO:0035456) | 2.73752669 |
| 126 | cellular response to interferon-beta (GO:0035458) | 2.73213541 |
| 127 | mature B cell differentiation (GO:0002335) | 2.72377994 |
| 128 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72228374 |
| 129 | pinocytosis (GO:0006907) | 2.70395092 |
| 130 | T cell receptor signaling pathway (GO:0050852) | 2.67928823 |
| 131 | myeloid leukocyte mediated immunity (GO:0002444) | 2.67433130 |
| 132 | regulation of response to interferon-gamma (GO:0060330) | 2.65587245 |
| 133 | positive regulation of macrophage differentiation (GO:0045651) | 2.65441259 |
| 134 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.63407299 |
| 135 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.63317962 |
| 136 | megakaryocyte development (GO:0035855) | 2.61706087 |
| 137 | leukocyte homeostasis (GO:0001776) | 2.61480805 |
| 138 | positive regulation of mast cell activation (GO:0033005) | 2.59827263 |
| 139 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.59692675 |
| 140 | translational termination (GO:0006415) | 2.59229693 |
| 141 | regulation of antigen processing and presentation (GO:0002577) | 2.58602779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.63053176 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.20262194 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.84829108 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.74037967 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.72288270 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.69491505 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.64652811 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.35979861 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.97620433 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.93499850 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.84136836 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79836431 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74333181 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.72501345 |
| 15 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.72418715 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.67195867 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.63534064 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.63504369 |
| 19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.62218150 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.61478113 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58702999 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.52083386 |
| 23 | * MYB_26560356_Chip-Seq_TH2_Human | 2.49765964 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.47709206 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.32111801 |
| 26 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.23167375 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19225450 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18364051 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18060167 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.15657249 |
| 31 | MYB_26560356_Chip-Seq_TH1_Human | 2.14403012 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13774164 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09674772 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 2.07641323 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.01078529 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96719093 |
| 37 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.95019487 |
| 38 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89910624 |
| 39 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82988510 |
| 40 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80730064 |
| 41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75784052 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.73161294 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.73016788 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66095391 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65408131 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65394268 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.56068366 |
| 48 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.51359903 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47982301 |
| 50 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.46013868 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45967994 |
| 52 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44718398 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43679431 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.43459689 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42198131 |
| 56 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40392230 |
| 57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37178688 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36391871 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35331578 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35239837 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34287283 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33855412 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32405939 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30771640 |
| 65 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29597673 |
| 66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28171430 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26687899 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26497155 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24725387 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.24713086 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23983385 |
| 72 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23303013 |
| 73 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22588674 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18512379 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16564407 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15609703 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14741059 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14560359 |
| 79 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13421335 |
| 80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13214870 |
| 81 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12699579 |
| 82 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12698828 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12357461 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12320283 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12001229 |
| 86 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.11244967 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11205219 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10800636 |
| 89 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09972876 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09409970 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08698629 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08099740 |
| 93 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.07915809 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07400884 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06931185 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05449014 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04958292 |
| 98 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03803338 |
| 99 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97644821 |
| 100 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.97286029 |
| 101 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96417702 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95814771 |
| 103 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95171984 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91305936 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91187185 |
| 106 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.90899781 |
| 107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90809987 |
| 108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.90085528 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89741400 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.88543794 |
| 111 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88018583 |
| 112 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86810188 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86583607 |
| 114 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85349192 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85268443 |
| 116 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.84004975 |
| 117 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82850032 |
| 118 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81861907 |
| 119 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81574061 |
| 120 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.80994757 |
| 121 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.80674726 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78802666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.00280316 |
| 2 | MP0003436_decreased_susceptibility_to | 3.26306007 |
| 3 | MP0000685_abnormal_immune_system | 3.24106818 |
| 4 | MP0005671_abnormal_response_to | 3.20160710 |
| 5 | MP0009785_altered_susceptibility_to | 3.19166948 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.02930669 |
| 7 | MP0001800_abnormal_humoral_immune | 2.98330110 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.90295346 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.84826525 |
| 10 | MP0005025_abnormal_response_to | 2.79500867 |
| 11 | MP0002419_abnormal_innate_immunity | 2.75430593 |
| 12 | MP0003303_peritoneal_inflammation | 2.74494953 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.74020196 |
| 14 | MP0001790_abnormal_immune_system | 2.72831422 |
| 15 | MP0005387_immune_system_phenotype | 2.72831422 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.69454013 |
| 17 | MP0001819_abnormal_immune_cell | 2.67138925 |
| 18 | MP0002723_abnormal_immune_serum | 2.67023368 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.54345029 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.49760282 |
| 21 | MP0002398_abnormal_bone_marrow | 2.47337746 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.40863816 |
| 23 | MP0002405_respiratory_system_inflammati | 2.23835571 |
| 24 | MP0000716_abnormal_immune_system | 2.22820741 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.19662605 |
| 26 | MP0002006_tumorigenesis | 2.10692843 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.08988528 |
| 28 | MP0001873_stomach_inflammation | 2.04637616 |
| 29 | MP0002722_abnormal_immune_system | 2.03465040 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 2.03445252 |
| 31 | MP0003724_increased_susceptibility_to | 1.99992641 |
| 32 | MP0006082_CNS_inflammation | 1.98270048 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.97655948 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.97655948 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.97505502 |
| 36 | MP0002429_abnormal_blood_cell | 1.91391814 |
| 37 | MP0005174_abnormal_tail_pigmentation | 1.88083351 |
| 38 | MP0009278_abnormal_bone_marrow | 1.87652063 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.83185129 |
| 40 | MP0001853_heart_inflammation | 1.78593129 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.77915190 |
| 42 | MP0004947_skin_inflammation | 1.75447059 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.74251347 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.70697338 |
| 45 | MP0004510_myositis | 1.62240455 |
| 46 | MP0008260_abnormal_autophagy | 1.58763966 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.58549782 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.57507848 |
| 49 | MP0000858_altered_metastatic_potential | 1.57472650 |
| 50 | MP0002933_joint_inflammation | 1.54351111 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.53265318 |
| 52 | MP0003866_abnormal_defecation | 1.49446218 |
| 53 | MP0000490_abnormal_crypts_of | 1.48737146 |
| 54 | MP0003448_altered_tumor_morphology | 1.39920842 |
| 55 | MP0008469_abnormal_protein_level | 1.36721957 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.35216195 |
| 57 | MP0003693_abnormal_embryo_hatching | 1.27153422 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.21604660 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.18707981 |
| 60 | MP0004883_abnormal_blood_vessel | 1.18176961 |
| 61 | MP0005310_abnormal_salivary_gland | 1.18102816 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.17698393 |
| 63 | MP0000343_altered_response_to | 1.15791826 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.12404272 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.12011248 |
| 66 | MP0005451_abnormal_body_composition | 1.07528435 |
| 67 | MP0001851_eye_inflammation | 1.06968890 |
| 68 | MP0010307_abnormal_tumor_latency | 1.06792555 |
| 69 | MP0000569_abnormal_digit_pigmentation | 1.01200048 |
| 70 | MP0010094_abnormal_chromosome_stability | 0.99950608 |
| 71 | MP0003077_abnormal_cell_cycle | 0.96368164 |
| 72 | MP0003690_abnormal_glial_cell | 0.95316447 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 0.93127704 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.91662758 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.89478707 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.88452440 |
| 77 | MP0005164_abnormal_response_to | 0.88100577 |
| 78 | MP0000604_amyloidosis | 0.88093219 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.87818433 |
| 80 | MP0009764_decreased_sensitivity_to | 0.87659187 |
| 81 | MP0008057_abnormal_DNA_replication | 0.83648156 |
| 82 | MP0003045_fibrosis | 0.78179399 |
| 83 | MP0003111_abnormal_nucleus_morphology | 0.77593493 |
| 84 | MP0002132_abnormal_respiratory_system | 0.75119179 |
| 85 | MP0009763_increased_sensitivity_to | 0.75050205 |
| 86 | MP0001663_abnormal_digestive_system | 0.75003291 |
| 87 | MP0005023_abnormal_wound_healing | 0.74823717 |
| 88 | MP0003828_pulmonary_edema | 0.73150630 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.71853460 |
| 90 | MP0008007_abnormal_cellular_replicative | 0.71038303 |
| 91 | MP0000371_diluted_coat_color | 0.69659362 |
| 92 | MP0005166_decreased_susceptibility_to | 0.69031789 |
| 93 | MP0005390_skeleton_phenotype | 0.67883966 |
| 94 | MP0006054_spinal_hemorrhage | 0.67740826 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.67711507 |
| 96 | MP0004957_abnormal_blastocyst_morpholog | 0.67113903 |
| 97 | MP0005076_abnormal_cell_differentiation | 0.64450924 |
| 98 | MP0000313_abnormal_cell_death | 0.63932761 |
| 99 | MP0004130_abnormal_muscle_cell | 0.63411183 |
| 100 | MP0003795_abnormal_bone_structure | 0.63175354 |
| 101 | MP0008004_abnormal_stomach_pH | 0.62707194 |
| 102 | MP0002009_preneoplasia | 0.61604196 |
| 103 | MP0003075_altered_response_to | 0.60635715 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.59913031 |
| 105 | MP0008874_decreased_physiological_sensi | 0.58043432 |
| 106 | MP0008058_abnormal_DNA_repair | 0.57312084 |
| 107 | MP0004381_abnormal_hair_follicle | 0.56307431 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.55717120 |
| 109 | MP0000249_abnormal_blood_vessel | 0.53726595 |
| 110 | MP0005083_abnormal_biliary_tract | 0.53270116 |
| 111 | MP0008873_increased_physiological_sensi | 0.52334484 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.51866928 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.51532254 |
| 114 | MP0005621_abnormal_cell_physiology | 0.49741278 |
| 115 | MP0009840_abnormal_foam_cell | 0.47790668 |
| 116 | MP0000350_abnormal_cell_proliferation | 0.47777125 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.43127448 |
| 118 | MP0000920_abnormal_myelination | 0.42331310 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.39908310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.65255401 |
| 2 | * Recurrent abscess formation (HP:0002722) | 5.48964872 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.06524284 |
| 4 | * Recurrent bacterial skin infections (HP:0005406) | 4.60419290 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.28414831 |
| 6 | Chronic otitis media (HP:0000389) | 4.24824352 |
| 7 | * Myositis (HP:0100614) | 4.14406567 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 4.06999991 |
| 9 | Obstructive lung disease (HP:0006536) | 4.06999991 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 4.06429718 |
| 11 | Thrombocytosis (HP:0001894) | 4.05140097 |
| 12 | IgM deficiency (HP:0002850) | 4.01805040 |
| 13 | Recurrent viral infections (HP:0004429) | 3.94697915 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.93973553 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.87966775 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.76163577 |
| 17 | Meningitis (HP:0001287) | 3.70309295 |
| 18 | Stomatitis (HP:0010280) | 3.57716821 |
| 19 | T lymphocytopenia (HP:0005403) | 3.53840126 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.49617564 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.41847417 |
| 22 | Recurrent bronchitis (HP:0002837) | 3.41151353 |
| 23 | Abnormality of T cell number (HP:0011839) | 3.40981811 |
| 24 | Abnormality of T cells (HP:0002843) | 3.38253163 |
| 25 | Nasal polyposis (HP:0100582) | 3.37520222 |
| 26 | * Recurrent skin infections (HP:0001581) | 3.34987532 |
| 27 | Orchitis (HP:0100796) | 3.34812275 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.29145056 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.29145056 |
| 30 | Retrobulbar optic neuritis (HP:0100654) | 3.26031797 |
| 31 | Optic neuritis (HP:0100653) | 3.26031797 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.25663508 |
| 33 | Hypochromic microcytic anemia (HP:0004840) | 3.20965016 |
| 34 | Cellulitis (HP:0100658) | 3.17563798 |
| 35 | Vasculitis (HP:0002633) | 3.09326574 |
| 36 | Hypochromic anemia (HP:0001931) | 3.07925522 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 3.06769945 |
| 38 | Abnormality of T cell physiology (HP:0011840) | 3.05441526 |
| 39 | Petechiae (HP:0000967) | 3.03613828 |
| 40 | Gingivitis (HP:0000230) | 2.98204793 |
| 41 | Increased IgM level (HP:0003496) | 2.94774902 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.92765003 |
| 43 | Prolonged bleeding time (HP:0003010) | 2.90701527 |
| 44 | Gastrointestinal inflammation (HP:0004386) | 2.86813939 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 2.85690551 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.85512262 |
| 47 | Episodic fever (HP:0001954) | 2.85426396 |
| 48 | Anorexia (HP:0002039) | 2.82370943 |
| 49 | Epistaxis (HP:0000421) | 2.76609673 |
| 50 | Eosinophilia (HP:0001880) | 2.76554118 |
| 51 | Hemoptysis (HP:0002105) | 2.72866270 |
| 52 | B lymphocytopenia (HP:0010976) | 2.72293916 |
| 53 | Abnormality of B cell number (HP:0010975) | 2.72293916 |
| 54 | Increased IgE level (HP:0003212) | 2.70514478 |
| 55 | Leukocytosis (HP:0001974) | 2.70411719 |
| 56 | Periodontitis (HP:0000704) | 2.69353147 |
| 57 | Chest pain (HP:0100749) | 2.65317380 |
| 58 | Encephalitis (HP:0002383) | 2.63572209 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.62594807 |
| 60 | Lymphopenia (HP:0001888) | 2.62522397 |
| 61 | Arterial thrombosis (HP:0004420) | 2.59087070 |
| 62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.56966220 |
| 63 | Granulocytopenia (HP:0001913) | 2.56086396 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55555051 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55555051 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55555051 |
| 67 | IgG deficiency (HP:0004315) | 2.53097342 |
| 68 | Thyroiditis (HP:0100646) | 2.52129727 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.51443422 |
| 70 | Gingival bleeding (HP:0000225) | 2.50293570 |
| 71 | Microcytic anemia (HP:0001935) | 2.46051329 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.44356170 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.41955917 |
| 74 | Amyloidosis (HP:0011034) | 2.40339399 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.39679789 |
| 76 | Abnormality of the fingertips (HP:0001211) | 2.38797580 |
| 77 | Osteomyelitis (HP:0002754) | 2.38271186 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 2.37736825 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.34582624 |
| 80 | Combined immunodeficiency (HP:0005387) | 2.34396521 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.32101864 |
| 82 | Loss of speech (HP:0002371) | 2.30615410 |
| 83 | Urticaria (HP:0001025) | 2.30050742 |
| 84 | Abnormality of the prostate (HP:0008775) | 2.28930478 |
| 85 | Colitis (HP:0002583) | 2.26579300 |
| 86 | Gangrene (HP:0100758) | 2.26231706 |
| 87 | Abnormal platelet function (HP:0011869) | 2.26139111 |
| 88 | Impaired platelet aggregation (HP:0003540) | 2.26139111 |
| 89 | Lymphoma (HP:0002665) | 2.25892996 |
| 90 | Purpura (HP:0000979) | 2.25816503 |
| 91 | Agammaglobulinemia (HP:0004432) | 2.24925302 |
| 92 | Peritonitis (HP:0002586) | 2.22007042 |
| 93 | Thoracic kyphosis (HP:0002942) | 2.21103780 |
| 94 | Increased serum ferritin (HP:0003281) | 2.20128356 |
| 95 | Hematochezia (HP:0002573) | 2.19229288 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18964784 |
| 97 | Keratoconjunctivitis (HP:0001096) | 2.18068095 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 2.15797122 |
| 99 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11993365 |
| 100 | Hepatosplenomegaly (HP:0001433) | 2.11049493 |
| 101 | Recurrent pneumonia (HP:0006532) | 2.10265570 |
| 102 | * Skin ulcer (HP:0200042) | 2.09027201 |
| 103 | Abnormal platelet volume (HP:0011876) | 2.07562532 |
| 104 | Basal ganglia calcification (HP:0002135) | 2.05704252 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 2.05167360 |
| 106 | Recurrent sinusitis (HP:0011108) | 2.04809310 |
| 107 | Reticulocytopenia (HP:0001896) | 2.04756006 |
| 108 | Sepsis (HP:0100806) | 2.04141452 |
| 109 | Glomerulopathy (HP:0100820) | 2.03858341 |
| 110 | Premature loss of primary teeth (HP:0006323) | 2.00493724 |
| 111 | Chronic sinusitis (HP:0011109) | 1.99353050 |
| 112 | Polyneuropathy (HP:0001271) | 1.99328523 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 1.99246631 |
| 114 | Amaurosis fugax (HP:0100576) | 1.99194427 |
| 115 | * Pustule (HP:0200039) | 1.98708411 |
| 116 | Agnosia (HP:0010524) | 1.97560044 |
| 117 | Pulmonary embolism (HP:0002204) | 1.96209516 |
| 118 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95859519 |
| 119 | Aplastic anemia (HP:0001915) | 1.95328177 |
| 120 | Chronic diarrhea (HP:0002028) | 1.94632247 |
| 121 | Emphysema (HP:0002097) | 1.93656457 |
| 122 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.93460825 |
| 123 | Vertigo (HP:0002321) | 1.93425776 |
| 124 | Acute hepatic failure (HP:0006554) | 1.93138578 |
| 125 | Keratitis (HP:0000491) | 1.92829749 |
| 126 | Abnormality of the endocardium (HP:0004306) | 1.92700219 |
| 127 | Dysostosis multiplex (HP:0000943) | 1.92131726 |
| 128 | Acute myeloid leukemia (HP:0004808) | 1.89944429 |
| 129 | Abnormality of the thoracic spine (HP:0100711) | 1.89463532 |
| 130 | Gastrointestinal stroma tumor (HP:0100723) | 1.89226502 |
| 131 | Slow saccadic eye movements (HP:0000514) | 1.88852314 |
| 132 | Joint swelling (HP:0001386) | 1.88301612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.78461425 |
| 2 | TXK | 3.09322570 |
| 3 | IRAK4 | 2.86485764 |
| 4 | KIT | 2.78154298 |
| 5 | BLK | 2.69348689 |
| 6 | JAK3 | 2.50532149 |
| 7 | ZAP70 | 2.48685790 |
| 8 | TYK2 | 2.40739705 |
| 9 | TBK1 | 2.37767879 |
| 10 | NME2 | 2.33375910 |
| 11 | BTK | 2.32031987 |
| 12 | TEC | 2.30331236 |
| 13 | EEF2K | 2.12587020 |
| 14 | PRPF4B | 2.02717752 |
| 15 | IKBKE | 2.00213040 |
| 16 | ITK | 1.94066293 |
| 17 | STK10 | 1.93744071 |
| 18 | RIPK4 | 1.89359833 |
| 19 | CSF1R | 1.89073184 |
| 20 | MAP3K14 | 1.88967226 |
| 21 | SYK | 1.84873955 |
| 22 | GRK6 | 1.78471615 |
| 23 | FES | 1.75438183 |
| 24 | FLT3 | 1.69206324 |
| 25 | MAP3K3 | 1.66900979 |
| 26 | HCK | 1.55355090 |
| 27 | MAP2K3 | 1.55112359 |
| 28 | CSK | 1.48873291 |
| 29 | * LCK | 1.47909287 |
| 30 | PKN2 | 1.45672610 |
| 31 | TAOK3 | 1.40534628 |
| 32 | IKBKB | 1.38002878 |
| 33 | JAK1 | 1.37533356 |
| 34 | IRAK3 | 1.34823423 |
| 35 | LRRK2 | 1.33771849 |
| 36 | EPHB1 | 1.26993938 |
| 37 | ERN1 | 1.22610048 |
| 38 | PIM1 | 1.19429282 |
| 39 | CLK1 | 1.18094816 |
| 40 | NLK | 1.16498826 |
| 41 | LYN | 1.14767579 |
| 42 | TRIB3 | 1.11404555 |
| 43 | TESK2 | 1.11328008 |
| 44 | CAMKK2 | 1.10882666 |
| 45 | MAP3K10 | 1.09638565 |
| 46 | PIM2 | 1.05834730 |
| 47 | FGFR4 | 1.02476032 |
| 48 | TRPM7 | 1.00375873 |
| 49 | MAP3K13 | 0.99390056 |
| 50 | MAP3K1 | 0.97522448 |
| 51 | RPS6KA4 | 0.94714018 |
| 52 | TGFBR2 | 0.91789631 |
| 53 | SIK2 | 0.91054425 |
| 54 | BMPR2 | 0.90367447 |
| 55 | MARK2 | 0.89047190 |
| 56 | KDR | 0.85819689 |
| 57 | FGFR3 | 0.85353615 |
| 58 | MARK3 | 0.82268306 |
| 59 | SCYL2 | 0.79306225 |
| 60 | TAOK2 | 0.76738065 |
| 61 | IRAK1 | 0.76331244 |
| 62 | JAK2 | 0.74530850 |
| 63 | KSR2 | 0.74167733 |
| 64 | STK4 | 0.72743780 |
| 65 | MAPK12 | 0.71457200 |
| 66 | MAP3K12 | 0.71412377 |
| 67 | CDK19 | 0.69704506 |
| 68 | CDK4 | 0.68336233 |
| 69 | CAMKK1 | 0.67915997 |
| 70 | PRKD2 | 0.67215648 |
| 71 | NEK2 | 0.66971854 |
| 72 | MAP3K7 | 0.66472622 |
| 73 | TTN | 0.65355554 |
| 74 | GRK7 | 0.63317257 |
| 75 | FYN | 0.63266022 |
| 76 | TNK2 | 0.62964755 |
| 77 | PDPK1 | 0.60529454 |
| 78 | CHUK | 0.60458621 |
| 79 | RPS6KB2 | 0.58790645 |
| 80 | MATK | 0.58665202 |
| 81 | PIK3CG | 0.58577814 |
| 82 | HIPK2 | 0.56906059 |
| 83 | MAPK7 | 0.56784226 |
| 84 | MST4 | 0.55014595 |
| 85 | PAK4 | 0.54611867 |
| 86 | CDC42BPA | 0.54313465 |
| 87 | STK11 | 0.53820187 |
| 88 | ADRBK2 | 0.53462738 |
| 89 | MAP3K11 | 0.52629094 |
| 90 | IRAK2 | 0.51846409 |
| 91 | PTK2B | 0.50371084 |
| 92 | MAPK4 | 0.50368411 |
| 93 | CDK12 | 0.50275286 |
| 94 | MAP3K6 | 0.49679305 |
| 95 | RPS6KA6 | 0.48418780 |
| 96 | TGFBR1 | 0.47164682 |
| 97 | CDC7 | 0.46098661 |
| 98 | CDK6 | 0.45431869 |
| 99 | ACVR1B | 0.45393742 |
| 100 | ATR | 0.45359549 |
| 101 | SMG1 | 0.43942165 |
| 102 | DYRK1B | 0.43877994 |
| 103 | PTK6 | 0.43606603 |
| 104 | PRKCQ | 0.42856787 |
| 105 | WEE1 | 0.42815898 |
| 106 | MAP3K8 | 0.42761934 |
| 107 | EPHA3 | 0.42400906 |
| 108 | MAP3K5 | 0.41601855 |
| 109 | EIF2AK3 | 0.41225801 |
| 110 | TAOK1 | 0.40391438 |
| 111 | MAP2K6 | 0.38579320 |
| 112 | ALK | 0.38442503 |
| 113 | BRSK2 | 0.38032445 |
| 114 | RPS6KC1 | 0.37291686 |
| 115 | RPS6KL1 | 0.37291686 |
| 116 | NEK9 | 0.36852377 |
| 117 | DAPK2 | 0.36834155 |
| 118 | MAPKAPK3 | 0.36057901 |
| 119 | MAPK11 | 0.35716242 |
| 120 | PDK1 | 0.35412525 |
| 121 | PRKCD | 0.35012447 |
| 122 | ILK | 0.34622913 |
| 123 | PRKG2 | 0.34056412 |
| 124 | SGK3 | 0.33721254 |
| 125 | MAPKAPK2 | 0.33098771 |
| 126 | MAP2K2 | 0.33013621 |
| 127 | MAP2K4 | 0.31959515 |
| 128 | FGR | 0.31799650 |
| 129 | STK24 | 0.30336083 |
| 130 | YES1 | 0.29564724 |
| 131 | SIK3 | 0.29462437 |
| 132 | CAMK4 | 0.28359646 |
| 133 | PRKCH | 0.27649194 |
| 134 | RET | 0.27182318 |
| 135 | SGK2 | 0.26990631 |
| 136 | SIK1 | 0.26791326 |
| 137 | STK38 | 0.26122531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.28668455 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85224638 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.33734860 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32644906 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.32161276 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.29545261 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28007472 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.21729636 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.19203954 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.07374224 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05501334 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01088968 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98152430 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97560066 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.90765118 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89577226 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.80329224 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.77009863 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75033381 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72016869 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65528143 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62897866 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51599735 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49855204 |
| 25 | Legionellosis_Homo sapiens_hsa05134 | 1.49702305 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.48742249 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.48455402 |
| 28 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45027400 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.42818525 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.42583579 |
| 31 | Mismatch repair_Homo sapiens_hsa03430 | 1.42266535 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38774622 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.37847240 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.37655679 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34610876 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33277611 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.33242398 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.28195319 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.28086612 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.25071190 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24140707 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 1.23767340 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.21520633 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16524565 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.14329432 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10161169 |
| 47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08920722 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 1.08157963 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.07232688 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05705963 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03429346 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02630086 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01506785 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.00269441 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97340712 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96508840 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94814240 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.94542164 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91322067 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85384750 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84433512 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.84232332 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80787561 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79751365 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.78512507 |
| 66 | Spliceosome_Homo sapiens_hsa03040 | 0.76844369 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76118615 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75922175 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.74577266 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73107271 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72553999 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71209610 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70253223 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70123928 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67845743 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.67407835 |
| 77 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.65551028 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64587522 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63295994 |
| 80 | Cell cycle_Homo sapiens_hsa04110 | 0.59015798 |
| 81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58929629 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56715769 |
| 83 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54770759 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54678044 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53489230 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53271395 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52819314 |
| 88 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52736602 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52241771 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.51867300 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51743352 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51355115 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50693475 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50298231 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49103660 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49037966 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48837172 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47990895 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46567096 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.45104090 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44520051 |
| 102 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44385384 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44201875 |
| 104 | Proteasome_Homo sapiens_hsa03050 | 0.43381104 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42733688 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40698901 |
| 107 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39180039 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38549227 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37784926 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.37626233 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37102880 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37095477 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36685358 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36527724 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36248145 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34841046 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.34339414 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32218195 |
| 119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31939197 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31045181 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30393647 |
| 122 | RNA transport_Homo sapiens_hsa03013 | 0.29540624 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.28377426 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27049225 |
| 125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.25345314 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23730113 |

